GSK:NYSE
GSK plc
46,55 US$
arrow_downward
-1,02%(-0,48) 1D
46,98 US$
arrow_upward
+0,92% (+0,43)todayPara orarit të tregut
Mbyllur: 5 tet, 4:00:02 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për GSK...
Hap
46,73 US$
I lartë
46,88 US$
I ulët
46,33 US$
Kapitalizimi i tregut
94,05 mld
Vëllimi mesatar
3,24 mln
Vëllimi
4,52 mijë
Dividendi
3,90%
Dividendi tremujor
0,45 US$
Data e ndërprerjes së dividendit
13 gush 2026
Raporti çmim/fitim
14,90
Maksimumi 52-javor
61,70 US$
Minimumi 52-javor
42,84 US$
Fitimet për aksion
3,12 US$
Beta
0,25
Aksionet në qarkullim
2,02 mld
Numri i punonjësve
67 mijë
Hap
46,73 US$
I lartë
46,88 US$
I ulët
46,33 US$
Kapitalizimi i tregut
94,05 mld
Vëllimi mesatar
3,24 mln
Vëllimi
4,52 mijë
Dividendi
3,90%
Dividendi tremujor
0,45 US$
Data e ndërprerjes së dividendit
13 gush 2026
Raporti çmim/fitim
14,90
Maksimumi 52-javor
61,70 US$
Minimumi 52-javor
42,84 US$
Fitimet për aksion
3,12 US$
Beta
0,25
Aksionet në qarkullim
2,02 mld
Numri i punonjësve
67 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
57 minuta më parë
Jefferies keeps Buy rating for GSK stock at GBp 2,500.00 target
Bioscience Association Manitoba
·
10 orë më parë
ViiV HEALTHCARE MAKES NEW £9.75 MILLION INVESTMENT TO ACCELERATE HIV RESPONSE FOR PAEDIATRIC AND ADOLESCENT POPULATION
Traders Union
·
1 ditë më parë
Why is GSK stock flat today? Resistance levels in focus
Profili
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Rreth GSK plc
Drejtori ekzekutivEmma Walmsley | Emma Walmsley
Punonjësit66,8 mijë
Themeluar më27 dhj 2000
Selia-
Sektori-
Uebsajtigsk.com